{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:03:29Z","timestamp":1783051409593,"version":"3.54.6"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112125","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T09:35:33Z","timestamp":1713864933000},"page":"112125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The potential role of SNHG16\/ miRNA-146a\/ TRAF6 signaling pathway in the protective effect of zoledronate against colorectal cancer and associated osteoporosis in mouse model"],"prefix":"10.1016","volume":"133","author":[{"given":"Amany","family":"Helmy Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Noureldin Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesma","family":"Hussein Abdel hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Fouad Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"El Sawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Sonbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Hussein Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112125_b0005","doi-asserted-by":"crossref","unstructured":"H.T. Lei, S. Yan, Y.H. He, N. Xu, M. Zhao, C.J. Yu, H.L. Li, S. Kuang, Z.H. Cui, J. Fang, J. Fang, Ki67 testing in the clinical management of patients with non-metastatic colorectal cancer: Detecting the optimal cut-off value based on the Restricted Cubic Spline model, Oncol. Lett., 24(6), 420. doi: 10.3892\/ol.2022.13540.","DOI":"10.3892\/ol.2022.13540"},{"key":"10.1016\/j.intimp.2024.112125_b0010","doi-asserted-by":"crossref","unstructured":"Bonetto Andrea, Kays Joshua K., Parker Valorie A., Matthews Ryan R., Barreto Rafael, Puppa Melissa J., Kang Kyung S., Carson James A., Guise Theresa A., Mohammad Khalid S., Robling Alexander G., Couch Marion E., Koniaris Leonidas G., Zimmers Teresa A. Differential Bone Loss in Mouse Models of Colon Cancer Cachexia. Front. Physiol. 7; 2017. Doi: 10.3389\/fphys.2016.00679.","DOI":"10.3389\/fphys.2016.00679"},{"key":"10.1016\/j.intimp.2024.112125_b0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11657-019-0629-7","article-title":"Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims","volume":"14","author":"Barzi","year":"2019","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.intimp.2024.112125_b0020","article-title":"LncRNA SNHG16 promotes colorectal cancer cell proliferation, migration, and epithelial\u2013mesenchymal transition through miR-124-3p\/MCP-1","volume":"1\u201313","author":"Chen","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.intimp.2024.112125_b0025","doi-asserted-by":"crossref","first-page":"e3296","DOI":"10.1002\/jgm.3296","article-title":"SNHG16\/miR-485-5p\/BMP7 axis modulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells","volume":"23","author":"Asila","year":"2021","journal-title":"J Gene Med."},{"key":"10.1016\/j.intimp.2024.112125_b0030","doi-asserted-by":"crossref","unstructured":"Yang M, Wei W. SNHG16: A Novel Long-Non Coding RNA in Human Cancers. Onco Targets Ther. 2019;12:11679-11690. Published 2019 Dec 31. doi:10.2147\/OTT.S231630.","DOI":"10.2147\/OTT.S231630"},{"key":"10.1016\/j.intimp.2024.112125_b0035","doi-asserted-by":"crossref","unstructured":"Ghafouri-Fard S, Khoshbakht T, Taheri M, Shojaei S. A Review on the Role of Small Nucleolar RNA Host Gene 6 Long Non-coding RNAs in the Carcinogenic Processes. Front Cell Dev Biol. 2021;9:741684. Published 2021 Oct 4. doi:10.3389\/fcell.2021.74168.","DOI":"10.3389\/fcell.2021.741684"},{"key":"10.1016\/j.intimp.2024.112125_b0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.intimp.2018.12.043","article-title":"Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1","volume":"68","author":"Wu","year":"2019","journal-title":"Int Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112125_b0045","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J Exp Med."},{"key":"10.1016\/j.intimp.2024.112125_b0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12195-021-00699-4","article-title":"Exosomes from Adipose Tissues Derived Mesenchymal Stem Cells Overexpressing MicroRNA-146a Alleviate Diabetic Osteoporosis in Rats","volume":"15","author":"Zhang","year":"2022","journal-title":"Cel. Mol. Bioeng."},{"key":"10.1016\/j.intimp.2024.112125_b0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12935-020-01517-z","article-title":"The relationship between TRAF6 and tumors","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.intimp.2024.112125_b0060","doi-asserted-by":"crossref","unstructured":"Song Ge , Zhang Yue , Tian Jie , Ma Jie , Yin Kai , Xu Huaxi , Wang Shengjun TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host Front. Immunol., 25 February 2021 Sec. Cancer Immunity and Immunotherapy Volume 12 - 2021 | doi: 10.3389\/fimmu.2021.649020.","DOI":"10.3389\/fimmu.2021.649020"},{"key":"10.1016\/j.intimp.2024.112125_b0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-020-1522-3","article-title":"KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation","volume":"39","author":"Li","year":"2020","journal-title":"J Exp Clin Cancer Res."},{"key":"10.1016\/j.intimp.2024.112125_b0070","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/cas.15302","article-title":"TRAF6 regulates the signaling pathway influencing colorectal cancer function through ubiquitination mechanisms","volume":"113","author":"Zhu","year":"2022","journal-title":"Cancer Science."},{"key":"10.1016\/j.intimp.2024.112125_b0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/iub.1066","article-title":"TRAF6 is upregulated in colon cancer and promotes proliferation of colon cancer cells","volume":"64","author":"Zhou","year":"2012","journal-title":"Iubmb Life."},{"key":"10.1016\/j.intimp.2024.112125_b0080","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1172\/JCI58818","article-title":"TRAF6 is an amplified oncogene bridging the RAS and NF-\u03baB pathways in human lung cancer","volume":"121","author":"Starczynowski","year":"2011","journal-title":"The Journal of Clinical Investigation."},{"key":"10.1016\/j.intimp.2024.112125_b0085","year":"2013","journal-title":"Molecular and Cellular Biology."},{"key":"10.1016\/j.intimp.2024.112125_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-018-1001-2","article-title":"RANKL\/RANK\/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives","volume":"38","author":"Infante","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.intimp.2024.112125_b0095","doi-asserted-by":"crossref","unstructured":"Guangwei Z, Zhibin C, Qin W, Chunlin L, Penghang L, Ruofan H, Hui C, Hoffman RM, Jianxin Y. TRAF6 regulates the signaling pathway influencing colorectal cancer function through ubiquitination mechanisms. Cancer Sci. 2022 Apr;113(4):1393-1405. doi: 10.1111\/cas.15302. Epub 2022 Mar 1. PMID: 35179811; PMCID: PMC8990288.","DOI":"10.1111\/cas.15302"},{"key":"10.1016\/j.intimp.2024.112125_b0100","doi-asserted-by":"crossref","first-page":"19807","DOI":"10.1002\/cam4.6552","article-title":"TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2-mediated glycolysis","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2024.112125_b0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41419-022-05524-y","article-title":"TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1\/RIPK3\/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer","volume":"14","author":"Lin","year":"2023","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.intimp.2024.112125_b0110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7150\/jca.90059","article-title":"Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic Potential","volume":"15","author":"Li","year":"2024","journal-title":"J Cancer."},{"key":"10.1016\/j.intimp.2024.112125_b0115","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1111\/jcmm.15399","article-title":"SNHG16\/miR-605-3p\/TRAF6\/NF-\u03baB feedback loop regulates hepatocellular carcinoma metastasis","volume":"24","author":"Hu","year":"2020","journal-title":"J Cell Mol Med."},{"key":"10.1016\/j.intimp.2024.112125_b0120","unstructured":"Li P, Yang H, Jia N, Jin X, Xu D, Shen Y. [Experimental study on inhibitory effect of zoledronic acid on the action style of the osteoclast]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2017 Feb;34(1):78-82. Chinese. doi: 10.7507\/1001-5515.201601041. PMID: 29717592; PMCID: PMC9935360."},{"key":"10.1016\/j.intimp.2024.112125_b0125","first-page":"582","article-title":"Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-\u03baB and JNK signalling pathways","volume":"44","author":"Huang","year":"2019","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.intimp.2024.112125_b0130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1186\/s12885-020-07568-9","article-title":"Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.intimp.2024.112125_b0135","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3748\/wjg.v26.i13.1394","article-title":"Mouse models of colorectal cancer: Past, present and future perspectives","volume":"26","author":"B\u00fcrtin","year":"2020","journal-title":"World J Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112125_b0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.2009.00160.x","article-title":"Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro","volume":"157","author":"R\u00e4ikk\u00f6nen","year":"2009","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.intimp.2024.112125_b0145","series-title":"Theory and practice of histological techniques","author":"Suvarna","year":"2013"},{"issue":"2","key":"10.1016\/j.intimp.2024.112125_b0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut."},{"key":"10.1016\/j.intimp.2024.112125_b0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.intimp.2024.112125_b0160","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The Incidence of Fracture among Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.intimp.2024.112125_b0165","doi-asserted-by":"crossref","first-page":"15144","DOI":"10.1038\/s41598-019-51550-w","article-title":"DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone","volume":"9","author":"Metzger","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.intimp.2024.112125_b0170","doi-asserted-by":"crossref","first-page":"e0132786","DOI":"10.1371\/journal.pone.0132786","article-title":"TGF-beta blockade reduces mortality and metabolic changes in a validated murine model of pancreatic cancer cachexia","volume":"10","author":"Greco","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2024.112125_b0175","doi-asserted-by":"crossref","first-page":"26041","DOI":"10.18632\/oncotarget.4667","article-title":"ZIP4 silencing improves bone loss in pancreatic cancer","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112125_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115104","article-title":"MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis","volume":"131","author":"Kocijan","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2024.112125_b0185","unstructured":"Cheng W, Hao CY, Zhao S, Zhang LL, Liu D. SNHG16 promotes the progression of osteoarthritis through activating microRNA-93-5p\/CCND1 axis. European Review for Medical & Pharmacological Sciences. 2019 Nov 1;23(21). doi: 10.26355\/eurrev_201911_19414."},{"key":"10.1016\/j.intimp.2024.112125_b0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12929-022-00849-4","article-title":"Down-regulated miR-146a expression with increased neutrophil extracellular traps and apoptosis formation in autoimmune-mediated diffuse alveolar hemorrhage","volume":"29","author":"Hsieh","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.intimp.2024.112125_b0195","doi-asserted-by":"crossref","unstructured":"Xie Y, Chu A, Feng Y, Chen L, Shao Y, Luo Q, Deng X, Wu M, Shi X and Chen Y: MicroRNA-146a: A comprehensive indicator of inflammation and oxidative stress status induced in the brain of chronic T2DM rats. Front Pharmacol. 9(478)2018. doi: 10.3389\/fphar.2018.00478.","DOI":"10.3389\/fphar.2018.00478"},{"key":"10.1016\/j.intimp.2024.112125_b0200","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/tox.22561","article-title":"MiR-146a regulates PM1 -induced inflammation via NF-\u03baB signaling pathway in BEAS-2B cells","volume":"33","author":"Liu","year":"2018","journal-title":"Environ Toxicol."},{"key":"10.1016\/j.intimp.2024.112125_b0205","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/art.30321","article-title":"The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis","volume":"63","author":"Nakasa","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.intimp.2024.112125_b0210","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41419-019-1901-x","article-title":"miR-146a attenuates apoptosis and modulates autophagy by targ Bernstein eting TAF9b\/P53 pathway in doxorubicin-induced cardiotoxicity","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.112125_b0215","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/1873-3468.12229","article-title":"MicroRNA-146a represses LRP2 translation and leads to cell apoptosis in Alzheimer's disease","volume":"590","author":"Zhang","year":"2016","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.intimp.2024.112125_b0220","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160578","article-title":"Effects of microRNA-146a on the proliferation and apoptosis of human osteoarthritis chondrocytes by targeting TRAF6 through the NF-\u03baB signalling pathway","volume":"37","author":"Zhong","year":"2017","journal-title":"Bioscience Reports."},{"key":"10.1016\/j.intimp.2024.112125_b0225","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.7150\/thno.40566","article-title":"A miR-146a-5p\/TRAF6\/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance","volume":"10","author":"Meng","year":"2020","journal-title":"Theranostics."},{"issue":"4","key":"10.1016\/j.intimp.2024.112125_b0230","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/jbmr.3031","article-title":"TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid","volume":"32","author":"Tan","year":"2017","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.intimp.2024.112125_b0235","doi-asserted-by":"crossref","unstructured":"Ryan T. Bishop, Silvia Marino, Giovana Carrasco, Boya Li, Richard J. Allen, Anna Sparatore, Penelope D. Ottewell, Patrick Mollat, Andrew H. Sims, Mattia Capulli, Ning Wang, Aymen I. Idris, Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis, Cancer Letters, Volume 488, 2020, Pages 27-39, ISSN 0304-3835, doi: 10.1016\/j.canlet.2020.05.021.","DOI":"10.1016\/j.canlet.2020.05.021"},{"key":"10.1016\/j.intimp.2024.112125_b0240","doi-asserted-by":"crossref","unstructured":"Abd Elwahab RM, Abdel Hamid NA. The Diagnostic Utility of Immunohistochemical expression of CDX2, CK7 and CK20 in Colorectal Adenocarcinoma. Zagazig University Medical Journal. 2023 Jan 1;29(1.1):368-75. 10.21608\/zumj.2019.16509.1479.doi:10.21608\/zumj.2019.16509.1479.","DOI":"10.21608\/zumj.2019.16509.1479"},{"key":"10.1016\/j.intimp.2024.112125_b0245","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s41416-021-01553-0","article-title":"Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin\u2013eosin-based morphologic parameters from the WHO classification","volume":"125","author":"Konukiewitz","year":"2021","journal-title":"Br J Cancer"},{"issue":"Supplement","key":"10.1016\/j.intimp.2024.112125_b0250","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.4103\/jcrt.JCRT_1723_20","article-title":"Pattern of expression of CDX2 in colorectal cancer and its role in prognosis","volume":"18","author":"Singh","year":"2022","journal-title":"J Cancer Res Ther."},{"issue":"2","key":"10.1016\/j.intimp.2024.112125_b0255","doi-asserted-by":"crossref","first-page":"644","DOI":"10.18203\/2320-6012.ijrms20190374","article-title":"Role of Ki67 protein in colorectal cancer","volume":"7","author":"Mulyawan","year":"2019","journal-title":"International Journal of Research in Medical Sciences"},{"key":"10.1016\/j.intimp.2024.112125_b0260","first-page":"1187","article-title":"Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC\u20138 stratification","volume":"43","author":"Tong","year":"2020","journal-title":"Oncology Reports"},{"key":"10.1016\/j.intimp.2024.112125_b0265","doi-asserted-by":"crossref","unstructured":"Oh Hyung-Hoon, Joo, Young-Eun Novel biomarkers for the diagnosis and prognosis of colorectal cancer. Intest Res. 2020;18(2):168-183. Published online November 30, 2019 doi: 10.5217\/ir.2019.00080.","DOI":"10.5217\/ir.2019.00080"},{"key":"10.1016\/j.intimp.2024.112125_b0270","doi-asserted-by":"crossref","unstructured":"Rashid Humaira, Hossain Biplob, Siddiqua Towfida, Kabir Mamun, Noor Zannatun, Ahmed Mamun, Haque Rashidul. Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases. Frontiers in Molecular Biosciences,7 2020 https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.00181.","DOI":"10.3389\/fmolb.2020.00181"},{"key":"10.1016\/j.intimp.2024.112125_b0275","first-page":"e23931","article-title":"Expression and Clinical Significance of Tumor Necrosis Factor Receptor-Associated Factor 6 in Patients With Colon Cancer","volume":"18","author":"Tao","year":"2016","journal-title":"Iranian Red Crescent Medical Journal."},{"issue":"1","key":"10.1016\/j.intimp.2024.112125_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190901","article-title":"Local vs. systemic administration of bisphosphonates in rat cleft bone graft: A comparative study","volume":"13","author":"Hong","year":"2018","journal-title":"Plos One."},{"key":"10.1016\/j.intimp.2024.112125_b0285","doi-asserted-by":"crossref","first-page":"e2094","DOI":"10.1038\/cddis.2016.11","article-title":"Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK\/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model","volume":"7","author":"Qiao","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112125_b0290","first-page":"89","article-title":"Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing","volume":"33","author":"Cui","year":"2018","journal-title":"Histol Histopathol."},{"key":"10.1016\/j.intimp.2024.112125_b0295","doi-asserted-by":"crossref","first-page":"41358","DOI":"10.1038\/srep41358","article-title":"Clomipramine causes osteoporosis by promoting osteoclastogenesis via E3 ligase itch, which is prevented by Zoledronic acid","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.intimp.2024.112125_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2020.05.021","article-title":"Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis","volume":"488","author":"Bishop","year":"2020","journal-title":"Cancer Letters."},{"issue":"94","key":"10.1016\/j.intimp.2024.112125_b0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2018.02.004","article-title":"Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01\/04) study","volume":"1","author":"Wilson","year":"2018","journal-title":"European Journal of Cancer."},{"issue":"20","key":"10.1016\/j.intimp.2024.112125_b0310","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2169\/internalmedicine.54.4430","article-title":"Synergistic anti-tumor effects of zoledronic acid and radiotherapy against metastatic hepatocellular carcinoma","volume":"54","author":"Morii","year":"2015","journal-title":"Int Med."},{"key":"10.1016\/j.intimp.2024.112125_b0315","doi-asserted-by":"crossref","first-page":"e878","DOI":"10.1038\/cddis.2013.406","article-title":"Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways","volume":"4","author":"Bruzzese","year":"2013","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.intimp.2024.112125_b0320","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/cas.13316","article-title":"Role of zoledronic acid in oncolytic virotherapy: promotion of antitumor effect and prevention of bone destruction","volume":"108","author":"Yamakawa","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2024.112125_b0325","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/cncr.26395","article-title":"Exposure to bisphosphonates and risk of colorectal cancer: a population-based nested case-control study","volume":"118","author":"Singh","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2024.112125_b0330","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2012.42.9530","article-title":"Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis","volume":"31","author":"Thosani","year":"2013","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.intimp.2024.112125_b0335","doi-asserted-by":"crossref","first-page":"44177","DOI":"10.1038\/srep44177","article-title":"Oral bisphosphonates and colorectal cancer","volume":"7","author":"Vogtmann","year":"2017","journal-title":"Sci Rep."},{"issue":"41","key":"10.1016\/j.intimp.2024.112125_b0340","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1038\/sj.onc.1207814","article-title":"The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate","volume":"23","author":"Caraglia","year":"2004","journal-title":"Oncogene."},{"issue":"12","key":"10.1016\/j.intimp.2024.112125_b0345","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.bjc.6600986","article-title":"Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro","volume":"88","author":"Tassone","year":"2003","journal-title":"Br J Cancer."},{"issue":"2","key":"10.1016\/j.intimp.2024.112125_b0350","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bone.2008.10.047","article-title":"Inhibition of bone resorption and growth of breast cancer in the bone microenvironment","volume":"44","author":"Buijs","year":"2009","journal-title":"Bone."},{"issue":"5","key":"10.1016\/j.intimp.2024.112125_b0355","first-page":"1807","article-title":"Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer","volume":"30","author":"Rack","year":"2010","journal-title":"Anticancer Res."},{"issue":"19","key":"10.1016\/j.intimp.2024.112125_b0360","doi-asserted-by":"crossref","first-page":"9346","DOI":"10.1158\/0008-5472.CAN-06-4508","article-title":"The activity of zoledronic acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation","volume":"67","author":"Peng","year":"2007","journal-title":"Cancer Res."},{"issue":"26","key":"10.1016\/j.intimp.2024.112125_b0365","doi-asserted-by":"crossref","first-page":"42926","DOI":"10.18632\/oncotarget.17216","article-title":"Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells","volume":"8","author":"Borghese","year":"2017","journal-title":"Oncotarget."},{"issue":"11","key":"10.1016\/j.intimp.2024.112125_b0370","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier","year":"2000","journal-title":"Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692400643X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692400643X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T21:40:36Z","timestamp":1731793236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692400643X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":74,"alternative-id":["S156757692400643X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112125","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role of SNHG16\/ miRNA-146a\/ TRAF6 signaling pathway in the protective effect of zoledronate against colorectal cancer and associated osteoporosis in mouse model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112125"}}